What is the official ID of this bill?
The official print number for this legislation is HR 8999.
Medicare Coverage and Payment for Dialysis-Related Amyloidosis Treatments.
This law ensures Medicare covers specialized, FDA-approved treatments for individuals suffering from dialysis-related amyloidosis (DRA). The change guarantees that these critical treatments are paid for fully and separately from standard dialysis services, aiming to improve patient access to necessary care.
Key points
Medicare must now cover FDA-approved treatments specifically targeting dialysis-related amyloidosis when provided in a dialysis facility.
Payment for these specialized treatments will be made separately at 100% of reasonable charges, ensuring providers are fully reimbursed outside of the standard bundled dialysis rate.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.